| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8660285 | Heart Rhythm | 2018 | 8 Pages |
Abstract
In paced patients with clinically symptomatic heart failure and LVEF <50%, pHBP upgrade was feasible in 88.9%, with improved left ventricular function and remodeling. Hence, pHBP can be an alternative for patients with pacing-induced cardiomyopathy and CRT nonresponders.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Peiren MD, Lan MD, Xiaodong MD, Shengjie MD, Lei MD, Fangyi MD, Xiaohong MD, Kenneth A. MD, FHRS, Weijian MD, FHRS,